Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.635
-0.185 (-4.84%)
May 12, 2026, 12:03 PM EDT - Market open
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $592.69 million as of May 12, 2026. Its market cap has increased by 819.70% in one year.
Market Cap
592.69M
Enterprise Value
508.20M
1-Year Change
819.70%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $592.69M, an increase of 151.64%. That is a compound annual growth rate of 15.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 632.63M | 200.08% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 678.99M |
| Sutro Biopharma | 666.69M |
| Zevra Therapeutics | 657.95M |
| Arvinas | 652.27M |
| Crescent Biopharma | 623.38M |
| CorMedix | 621.26M |
| BridgeBio Oncology Therapeutics | 613.05M |
| Candel Therapeutics | 611.81M |